Over 5,000 women present with ovarian cancer each year in England and Wales, with an associated mortality rate of approximately 4,000, making this the most common cause of death from gynaecological malignancies (OPCS, 1993) . Recognised prognostic indicators include age, performance status, disease stage, presenting and residual tumour load, tumour histology and differentiation, tumour ploidy patterns, the presence of ascitic fluid and response to chemotherapy (Friedlander & Dembo, 1991; Lund & Williamson, 1991) . Surgical staging with a hysterectomy, bilateral salpingooophorectomy and omentectomy, followed by adjuvant chemotherapy, is the basis of treatment in many cases. If not all the tumour can be excised, debulkling of disease is recommended, as such an approach is presently considered to improve outcome (DOH, 1991) . Owing to the non-specific symptoms in ovarian cancer, many patients are primarily referred to other specialists (Timm, 1973) , and inevitably not all are operated on by a gynaecologist. The FIGO (1977) criteria.
Statistical analysis was undertaken using the BMDP statistical package (BDMP, 1981) . Only patients for whom the operating surgeon was known were included. Patients were grouped for analysis according to the specialty of the surgeon (gynaecologist or general surgeon). Univariate methods (Mann-Whitney U-test and standard error of differences in proportions) (Armitage & Berry, 1987) were used to examine the characterstics of both groups. Survival was analysed using Kaplan-Meier (Kaplan & Meier, 1958) Various reasons may be forwarded, explaining the differences found in survival patterns between the populations studied. The most obvious is that of the patients' age. Survival in elderly patients with ovarian cancer is poorer even if adequate surgery and chemotherapy is employed (Alberts et al., 1993; Marchetti et al., 1993 General surg Tab H Univariate years) with widespread intra-abdominal disease, which could explain the poor outcome of this small group. Besides age, the referral patterns probably differ as demonstrated by the higher incidence of bowel resection in those under the care of general surgeons. General surgeons are more likely to deal with such patients -a group in a poorer physical condition, which in some cases require emergency intervention. Our findings may reflect the inherent adverse survival patterns associated with such a population. Although a reasonable conclusion, this does not explain the poorer survival in younger patients and those with stage I/II disease, operated on by general surgeons. Also of concern is the fact that general surgeons more often undertake oophorectomy alone in early-stage disease, which could affect survival rates. One interpretation of these findings is the tendency for the operator to perform procedures they are trained in, and to limit their surgical approach in unfamiliar circumstances. The differences in the frequency of general surgeons and gynaecologists in operating on patients could lead to the assumption that experience alone is an important factor. Reports on this aspect pertaining to bladder cancer (Guillford et al., 1991) suggest that variables other than experience account for differing survival patterns, though series on oesophageal cancer (Matthews et al., 1986) found surgical experience a contributor to survival rates.
The importance of prognostic factors in any malignancy cannot be adequately sressed. More often than not, these variables are outside the patients' and doctors' control. Identifying prognostic indicators which are amenable to change gives rise to the possibility of altering practice and influencing survival, which is particularly relevant to ovarian cancer. We recognise the inherent dangers of retrospective analysis and that other factors may account for some of the results in this study. Such variables can only be eliminated by a prospective randomised trial, the ethics of which would be questionable. The accuracy of information available is another variable, and an estimate error of 3% can be assumed by the fact that 18 patients did not have malignancy and 33 were duplicate records.
We suggest that the evidence from this series is sufficient to justify a recomnendation that every attempt should be made to ensure that all patients with ovarian pathology are treated by or have the involvement of a trained gynaecologist.
Adherence to such a policy could well improve patient survival in ovarian cancer.
